These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 27716814)

  • 1. Low Levels of NDRG1 in Nerve Tissue Are Predictive of Severe Paclitaxel-Induced Neuropathy.
    Sundar R; Jeyasekharan AD; Pang B; Soong RC; Kumarakulasinghe NB; Ow SG; Ho J; Lim JS; Tan DS; Wilder-Smith EP; Bandla A; Tan SS; Asuncion BR; Fazreen Z; Hoppe MM; Putti TC; Poh LM; Goh BC; Lee SC
    PLoS One; 2016; 11(10):e0164319. PubMed ID: 27716814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concomitant Medications and Risk of Chemotherapy-Induced Peripheral Neuropathy.
    Sánchez-Barroso L; Apellaniz-Ruiz M; Gutiérrez-Gutiérrez G; Santos M; Roldán-Romero JM; Curras M; Remacha L; Calsina B; Calvo I; Sereno M; Merino M; García-Donas J; Castelo B; Guerra E; Letón R; Montero-Conde C; Cascón A; Inglada-Pérez L; Robledo M; Rodríguez-Antona C
    Oncologist; 2019 Aug; 24(8):e784-e792. PubMed ID: 30470691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the effect of N-acetylcysteine on the prevention and amelioration of paclitaxel-induced peripheral neuropathy in breast cancer patients: a randomized controlled study.
    Khalefa HG; Shawki MA; Aboelhassan R; El Wakeel LM
    Breast Cancer Res Treat; 2020 Aug; 183(1):117-125. PubMed ID: 32601973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for the development of paclitaxel-induced neuropathy in breast cancer patients.
    Robertson J; Raizer J; Hodges JS; Gradishar W; Allen JA
    J Peripher Nerv Syst; 2018 Jun; 23(2):129-133. PubMed ID: 29696771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole-exome sequencing reveals defective CYP3A4 variants predictive of paclitaxel dose-limiting neuropathy.
    Apellániz-Ruiz M; Lee MY; Sánchez-Barroso L; Gutiérrez-Gutiérrez G; Calvo I; García-Estévez L; Sereno M; García-Donás J; Castelo B; Guerra E; Leandro-García LJ; Cascón A; Johansson I; Robledo M; Ingelman-Sundberg M; Rodríguez-Antona C
    Clin Cancer Res; 2015 Jan; 21(2):322-8. PubMed ID: 25398452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for paclitaxel-induced peripheral neuropathy in patients with breast cancer.
    Ghoreishi Z; Keshavarz S; Asghari Jafarabadi M; Fathifar Z; Goodman KA; Esfahani A
    BMC Cancer; 2018 Oct; 18(1):958. PubMed ID: 30290775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The early onset of peripheral neuropathy might be a robust predictor for time to treatment failure in patients with metastatic breast cancer receiving chemotherapy containing paclitaxel.
    Fukada I; Ito Y; Kobayashi K; Shibayama T; Takahashi S; Horii R; Akiyama F; Iwase T; Ohno S
    PLoS One; 2017; 12(9):e0184322. PubMed ID: 28898275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and functional characterization of two missense mutations in NDRG1 associated with Charcot-Marie-Tooth disease type 4D.
    Li LX; Liu GL; Liu ZJ; Lu C; Wu ZY
    Hum Mutat; 2017 Nov; 38(11):1569-1578. PubMed ID: 28776325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of the Charcot-Marie-Tooth disease gene ARHGEF10 with paclitaxel induced peripheral neuropathy in NCCTG N08CA (Alliance).
    Boora GK; Kulkarni AA; Kanwar R; Beyerlein P; Qin R; Banck MS; Ruddy KJ; Pleticha J; Lynch CA; Behrens RJ; Züchner S; Loprinzi CL; Beutler AS
    J Neurol Sci; 2015 Oct; 357(1-2):35-40. PubMed ID: 26143528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A genome-wide association study identifies novel loci for paclitaxel-induced sensory peripheral neuropathy in CALGB 40101.
    Baldwin RM; Owzar K; Zembutsu H; Chhibber A; Kubo M; Jiang C; Watson D; Eclov RJ; Mefford J; McLeod HL; Friedman PN; Hudis CA; Winer EP; Jorgenson EM; Witte JS; Shulman LN; Nakamura Y; Ratain MJ; Kroetz DL
    Clin Cancer Res; 2012 Sep; 18(18):5099-109. PubMed ID: 22843789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutamine as a neuroprotective agent in high-dose paclitaxel-induced peripheral neuropathy: a clinical and electrophysiologic study.
    Stubblefield MD; Vahdat LT; Balmaceda CM; Troxel AB; Hesdorffer CS; Gooch CL
    Clin Oncol (R Coll Radiol); 2005 Jun; 17(4):271-6. PubMed ID: 15997923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of paclitaxel-induced peripheral neuropathy with glutamine.
    Vahdat L; Papadopoulos K; Lange D; Leuin S; Kaufman E; Donovan D; Frederick D; Bagiella E; Tiersten A; Nichols G; Garrett T; Savage D; Antman K; Hesdorffer CS; Balmaceda C
    Clin Cancer Res; 2001 May; 7(5):1192-7. PubMed ID: 11350883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of height on paclitaxel nerve damage.
    Openshaw H; Beamon K; Longmate J; Synold T; Slatkin NE; Somlo G
    J Neurooncol; 2005 Sep; 74(2):207-10. PubMed ID: 16193394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Charcot-Marie-Tooth gene, SBF2, associated with taxane-induced peripheral neuropathy in African Americans.
    Schneider BP; Lai D; Shen F; Jiang G; Radovich M; Li L; Gardner L; Miller KD; O'Neill A; Sparano JA; Xue G; Foroud T; Sledge GW
    Oncotarget; 2016 Dec; 7(50):82244-82253. PubMed ID: 27732968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ndrg1 in development and maintenance of the myelin sheath.
    King RH; Chandler D; Lopaticki S; Huang D; Blake J; Muddle JR; Kilpatrick T; Nourallah M; Miyata T; Okuda T; Carter KW; Hunter M; Angelicheva D; Morahan G; Kalaydjieva L
    Neurobiol Dis; 2011 Jun; 42(3):368-80. PubMed ID: 21303696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversible paclitaxel-induced vocal cord paralysis with later recall with vinorelbine.
    Choi BS; Robins HI
    Cancer Chemother Pharmacol; 2008 Feb; 61(2):345-6. PubMed ID: 18026678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the efficacy of cryotherapy and compression therapy for preventing nanoparticle albumin-bound paclitaxel-induced peripheral neuropathy: A prospective self-controlled trial.
    Kanbayashi Y; Sakaguchi K; Ishikawa T; Ouchi Y; Nakatsukasa K; Tabuchi Y; Kanehisa F; Hiramatsu M; Takagi R; Yokota I; Katoh N; Taguchi T
    Breast; 2020 Feb; 49():219-224. PubMed ID: 31901783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of Charcot-Marie-Tooth disease gene mitofusin 2 expression in paclitaxel-induced mechanical allodynia in rats.
    Yamashita Y; Irie K; Kochi A; Kimura N; Hayashi T; Matsuo K; Myose T; Sano K; Nakano T; Takase Y; Nakamura Y; Satho T; Mishima K; Mishima K
    Neurosci Lett; 2017 Jul; 653():337-340. PubMed ID: 28587902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Taxane-Induced Peripheral Neuropathy: Objective and Subjective Comparison Between Paclitaxel and Docetaxel in Patients With Breast Cancer.
    Chan YN; Jheng YW; Wang PJ; Chen CY; Lin MW; Wang YJ
    Clin J Oncol Nurs; 2019 Oct; 23(5):494-501. PubMed ID: 31538967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurophysiological study of peripheral neuropathy after high-dose Paclitaxel: lack of neuroprotective effect of amifostine.
    Openshaw H; Beamon K; Synold TW; Longmate J; Slatkin NE; Doroshow JH; Forman S; Margolin K; Morgan R; Shibata S; Somlo G
    Clin Cancer Res; 2004 Jan; 10(2):461-7. PubMed ID: 14760066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.